Effect of IBD medications on COVID-19 outcomes: results from an international registry

OBJECTIVE: We sought to evaluate COVID-19 clinical course in patients with IBD treated with different medication classes and combinations. DESIGN: Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) is a large, international registry created...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Gut
Autors principals: Ungaro, Ryan C, Brenner, Erica J, Gearry, Richard B, Kaplan, Gilaad G, Kissous-Hunt, Michele, Lewis, James D, Ng, Siew C, Rahier, Jean-Francois, Reinisch, Walter, Steinwurz, Flávio, Underwood, Fox E, Zhang, Xian, Colombel, Jean-Frederic, Kappelman, Michael D
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2021
Matèries:
Covid-19
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8136807/
https://ncbi.nlm.nih.gov/pubmed/33082265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2020-322539
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars